When standard anxiety treatment has not worked well enough
Anxiety treatment can stall for several reasons. Sometimes the diagnosis is incomplete. Sometimes the medication trial was too short or too hard to tolerate. Sometimes trauma, untreated ADHD, sleep problems, substance use, or a medical issue is keeping symptoms active. For most anxiety disorders, the best-supported starting point is still CBT or exposure-based therapy plus an SSRI or SNRI. (AAFP)
Treatment-Resistant Anxiety Treatment Online
What this term usually means
“Treatment-resistant anxiety” is a practical phrase, not one single diagnosis. In consensus definitions, it usually means anxiety that has not improved enough after at least one adequate first-line medication trial and at least one adequate course of first-line psychotherapy, usually CBT. (PMC)
Standard treatments worth reviewing first
Before moving to later-line options, it is worth checking whether the standard treatments were truly tried in the right way. That usually means structured therapy and a medication trial at an adequate dose and for long enough. (AAFP)
CBT and exposure-based therapy
SSRIs
SNRIs
Broader medication options
There have been very few truly new approved anxiety medications in recent years. That does not mean treatment stops at the first SSRI. It means good care often depends on knowing the broader set of less commonly used options and when they make sense. (PMC)
Buspirone
Buspirone is a reasonable option, especially for generalized anxiety. It works gradually and is usually more useful for chronic worry than for sudden panic. (PMC)
Pregabalin (Lyrica)
Pregabalin is one of the better-supported non-antidepressant options for generalized anxiety. NICE recommends considering it when SSRIs or SNRIs are not tolerated. Common downsides include dizziness, sedation, and weight gain, and misuse risk still needs attention. (NICE)
Hydroxyzine (Vistaril)
Hydroxyzine is often used for short-term relief. It can help when anxiety is paired with insomnia, physical tension, or agitation. It is usually a bridge or add-on, not the main long-term plan. (PMC)
Propranolol
Propranolol is most useful for the physical side of anxiety, such as rapid heartbeat, tremor, flushing, or performance anxiety. It is less convincing as a treatment for ongoing generalized worry. (PMC)
Other antidepressant strategies
In selected cases, clinicians may also consider medication switches or less commonly used antidepressants, such as mirtazapine or tricyclics, when sleep, side effects, or partial response make that reasonable. (PMC)
Later-line and high-caution options
Some cases do need later-line treatment. These options can matter, but they also require more caution, closer follow-up, and a clearer reason for use. (NICE)
Gabapentin (Neurontin)
Gabapentin is used off label for anxiety, but the evidence is thinner than it is for pregabalin. It may help in some cases, but it is not one of the strongest evidence-based next steps for chronic anxiety. (PMC)
Low-dose atypical antipsychotic augmentation
Low-dose atypical antipsychotics are sometimes used in difficult cases. Quetiapine has the strongest data in this group, but sedation, weight gain, and metabolic side effects limit routine use. NICE advises against offering antipsychotics routinely for generalized anxiety in primary care. (NICE)
Benzodiazepines
Benzodiazepines work quickly, but they are not first-line treatment and are not good long-term anchor medications for most anxiety care. Dependence, withdrawal, rebound anxiety, falls, and cognitive side effects all matter. (AAFP)
PTSD-related nightmares
Prazosin has a narrower role. Its best-supported use is for nightmares associated with PTSD. It is not a general medication for routine anxiety. (Health Quality)
Medical and lab review
When anxiety has not improved, it is worth checking whether something else is adding to the picture. Medical contributors can include hyperthyroidism, arrhythmias, asthma, COPD, heart failure, Cushing syndrome, pheochromocytoma, and medication effects such as albuterol or corticosteroids. Substance use and withdrawal can also make anxiety harder to treat. (Merck Manuals)
Magnesium
Magnesium is not a routine anxiety treatment, but it can be relevant when deficiency risk is present. NIH notes that low magnesium is more likely with gastrointestinal disease, diabetes, alcohol dependence, or older age. (Office of Dietary Supplements)
Vitamin B6
Vitamin B6 is not a standard anxiety treatment. High doses can cause sensory neuropathy, and the NIH fact sheet lists an adult upper limit of 100 mg per day. (Office of Dietary Supplements)
Vitamin B12 and folate
B12 and folate are more useful when the history suggests anemia, neuropathy, restrictive diet, GI surgery, malabsorption, or medication-related deficiency. B12 deficiency can cause fatigue, palpitations, anemia, and neurologic symptoms. (Office of Dietary Supplements)
Untreated ADHD
Untreated ADHD can look like anxiety or make anxiety harder to treat. Chronic overwhelm, poor follow-through, internal restlessness, and emotional dysregulation can keep anxiety active even when the main complaint sounds like worry. Adult ADHD also commonly co-occurs with anxiety disorders. (PMC)
Newer and investigational treatments
Research is active, but routine anxiety care has changed less than many people assume. There have been few truly new approved anxiety medications in recent years, and most everyday care still rests on good diagnosis, CBT, SSRIs or SNRIs, and selective use of later-line options. (PMC)
What comprehensive anxiety care looks like
A thorough evaluation usually includes:review of prior medications and side effectsreview of therapy type and durationscreening for ADHD, trauma, sleep, and substance usereview of medical contributors consideration of broader or later-line medication options when appropriateWhen a less commonly used treatment makes sense, the plan should also include the documentation needed to pursue coverage and the follow-up needed to use it safely.
Adjunctive options
Some non-medication options can help, especially when they are used as part of a broader plan rather than as stand-alone fixes. (PMC)
Biofeedback
Heart-rate-variability biofeedback has meta-analytic support for reducing stress and anxiety symptoms. It is usually best used as an add-on, not a replacement for therapy or medication. (PubMed)
Specific probiotic strains
Probiotic effects are strain-specific. A 2024 meta-analysis found mixed overall results, but some strains, including Lactobacillus plantarum DR7 and Bifidobacterium longum 1714, have supportive human data. (PMC)
Online anxiety care at Ann Arbor Psych
Ann Arbor Psych provides online psychiatric evaluation and treatment for anxiety, including more complex cases where first-line treatment has not helped enough.
Our approach includes:
careful review of what has already been tried
evidence-based first-line treatment
broader medication options when appropriate
screening for coexisting psychiatric and medical factors
individualized treatment planning
Clinically Reviewed By: